Bath & Body Works, Inc. (NYSE:BBWI) Insider Thomas E. Mazurek Sells 4,285 Shares

Bath & Body Works, Inc. (NYSE:BBWI) insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Bath & Body Works Price Performance

BBWI stock traded up $0.57 on Thursday, reaching $50.02. 2,257,412 shares of the company were exchanged, compared to its average volume of 2,789,631. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.17. The stock’s fifty day moving average price is $45.05 and its 200 day moving average price is $38.74. The firm has a market capitalization of $11.25 billion, a PE ratio of 12.84, a PEG ratio of 1.60 and a beta of 1.85.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same quarter in the previous year, the firm posted $1.86 earnings per share. Bath & Body Works’s revenue was up .8% compared to the same quarter last year. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Thursday, February 22nd. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.78%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of recent research reports. TD Cowen raised their price target on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Barclays lowered Bath & Body Works from an “overweight” rating to an “equal weight” rating and raised their target price for the company from $37.00 to $45.00 in a report on Thursday, January 4th. Wells Fargo & Company upped their price target on Bath & Body Works from $40.00 to $42.00 and gave the stock an “equal weight” rating in a research note on Friday, March 1st. The Goldman Sachs Group raised their price objective on Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Finally, BMO Capital Markets boosted their target price on Bath & Body Works from $48.00 to $50.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $45.80.

Hedge Funds Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently bought and sold shares of BBWI. Front Row Advisors LLC bought a new stake in Bath & Body Works in the 3rd quarter valued at $25,000. Trust Co. of Vermont bought a new stake in Bath & Body Works in the 3rd quarter valued at $27,000. Denali Advisors LLC bought a new stake in Bath & Body Works in the 4th quarter valued at $27,000. GAMMA Investing LLC bought a new stake in Bath & Body Works in the 4th quarter valued at $27,000. Finally, Money Concepts Capital Corp increased its holdings in Bath & Body Works by 1,180.4% in the 4th quarter. Money Concepts Capital Corp now owns 653 shares of the company’s stock valued at $28,000 after buying an additional 602 shares during the period. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.